Polymeric RNAi Microsponge Delivery Simultaneously Targeting Multiple Genes for Novel Pathway Inhibition of Ovarian Cancer
Technical Report,30 Sep 2015,29 Sep 2016
Massachusetts General Hospital Boston United States
Pagination or Media Count:
The first year of this award included the following tasks. Major Task 1 IACUC and ACURO Approval. Subtask 1 IACUC Approval. Months 1 - 3. Subtask 2 Acuro Approval. Months 3 - 6. Milestones Achieved We obtained the necessary approvals for performing animal experiments. Major Task 2 Synthesis and in vitro testing of single component RNAi-MS. Subtask 1 Synthesis of single component RNAi-MS. Months 1-3. Subtask 2 Target product inhibition by single component RNAi. Months 1-3. Subtask 3 Single component RNAi-MS mediated inhibition of in vitro cancer cell tumorigenic behavior. Months-4-8. This task is still ongoing we will accomplish by end of this no cost extension year, 7312017. Major Task 3 Synthesis and in vitro testing of multiple component RNAi-MS. Months 4-12. This task is in progress.
- Medicine and Medical Research